4.6 Review

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 105, 期 5, 页码 1095-1105

出版社

WILEY
DOI: 10.1002/cpt.1304

关键词

-

资金

  1. National Institutes of Health (CPIC) [R24GM115264, U24HG010135]
  2. National Institutes of Health (PharmGKB) [R24GM61374, R01GM118578, P50GM115279]

向作者/读者索取更多资源

Thiopurine methyltransferase (TPMT) activity exhibits a monogenic codominant inheritance and catabolizes thiopurines. TPMT variant alleles are associated with low enzyme activity and pronounced pharmacologic effects of thiopurines. Loss-of-function alleles in the NUDT15 gene are common in Asians and Hispanics and reduce the degradation of active thiopurine nucleotide metabolites, also predisposing to myelosuppression. We provide recommendations for adjusting starting doses of azathioprine, mercaptopurine, and thioguanine based on TPMT and NUDT15 genotypes (updates on ).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据